首页> 外文期刊>Key Engineering Materials >In Vivo Chondrogenesis of Bmscs at Non-Chondrogenesis Site by Co-Transplantation of BMSCs and Chondrocytes with Pluronic as Biomaterial
【24h】

In Vivo Chondrogenesis of Bmscs at Non-Chondrogenesis Site by Co-Transplantation of BMSCs and Chondrocytes with Pluronic as Biomaterial

机译:以普朗尼克为生物材料共移植BMSCs和软骨细胞在非软骨形成部位的Bmscs体内软骨形成

获取原文
获取原文并翻译 | 示例
       

摘要

Bone Marrow Stromal Cells (BMSCs) have chondrogenesis potential if chondrogenic environments or factors are provided. This study tests the hypothesis that chondrocytes can promote BMSC chondrogenesis at non-chondrogensis site. Porcine BMSCs and auricular chondrocytes were mixed at different ratios and 2.5 x 10~7 mixed cells were resuspended in 0.5 ml 30% Pluronic, and then the mixture was injected into nude mice subcutaneously as experimental groups. Chondrocytes or BMSCs at the same cell number were mixed with 0.5 ml Pluronic and injected respectively as controls. 2.5 x 10~7 chondrocytes were mixed and injected as low concentration chondrocyte control. 8 weeks later, all specimens in experimental groups and chondrocyte group formed mature cartilage with abundant collagen Ⅱ expression. Mature lacuna structures and metachromatic matrices were also observed in these specimens with the same level of GAG contents. Average wet weight of specimens in experimental groups was over 70% of that in chondrocyte group. In contrast, specimens in BMSC group showed mainly fibrous tissue. Only a small amount of cartilage was formed in specimens of low concentration chondrocyte group and the average wet weight was below 30% of that in chondrocyte group. These results demonstrate that chondrocytes can provide chondrogenic microenvironment and thus promote in vivo chondrogenesis of BMSCs at non-chondrogenesis sites. It also indicates that Pluronic is an ideal injectable biomaterial for cartilage tissue engineering.
机译:如果提供软骨形成环境或因素,则骨髓基质细胞(BMSC)具有软骨形成的潜力。这项研究检验了这样的假设,即软骨细胞可以促进非软骨细胞部位的BMSC软骨形成。将猪骨髓间充质干细胞和耳软骨细胞以不同比例混合,然后将2.5 x 10〜7个混合细胞重悬于0.5 ml 30%Pluronic中,然后将其作为实验组皮下注射到裸鼠中。将具有相同细胞数的软骨细胞或BMSC与0.5 ml Pluronic混合,分别注射作为对照。混合2.5×10〜7个软骨细胞并注射作为低浓度软骨细胞对照。 8周后,实验组和软骨细胞组的所有标本均形成了成熟的软骨,具有丰富的Ⅱ型胶原表达。在这些样品中还观察到了成熟的空隙结构和变色基质,GAG含量相同。实验组标本的平均湿重是软骨细胞组的70%以上。相反,BMSC组的标本主要显示纤维组织。低浓度软骨细胞组的样本中仅形成少量软骨,平均湿重低于软骨细胞组的平均湿重的30%。这些结果表明软骨细胞可以提供软骨微环境,从而促进非软骨形成位点的骨髓间充质干细胞的体内软骨形成。这也表明Pluronic是用于软骨组织工程的理想可注射生物材料。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号